Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Bottomline: PE-backed Zenex gets a boost with Ayurvet M&A, explores new growth areas
Zenex Animal Health India Pvt Ltd, formed after private equity firm Multiples PE and a consortium of investors acquired ......
Healthcare
Strategic investor, early-stage VC funds set to back medtech startup Larkai
A strategic investor that itself is raising over $40 million in fresh capital is likely to lead an early-stage funding ......
Healthcare
PE firm InvAscent bets on geriatric care services provider
Healthcare-focused private equity firm InvAscent, which is raising its fourth fund and struck three new deals from the ......
Healthcare
Deals Digest: PE firms swing in action but M&As remain tepid
Deal activity in India picked up in the week gone by as several private equity firms struck transactions across ......
Healthcare
Searchlight: Drugmaker Credo Life may hit revenue bump as key product faces headwinds
Credo Life Sciences Pvt Ltd managed a healthy growth in revenue for the year ended March 2024, but the ongoing ......
Healthcare
Lightrock, 360 One-backed Kauvery Hospital weighs public listing
Tamil Nadu-based Kauvery Hospital, which is backed by private equity investors 360 One Asset Management, Stakeboat ......
Finance
Manipal Hospitals backer Novo Holdings names former KKR exec as India head
Danish investment firm Novo Holdings, which has invested in Manipal Hospitals and Qure.ai Technologies in India, has ......
Healthcare
Morgan Stanley PE ramps up India healthcare play with bet on urology chain
A private equity fund managed by Wall Street firm Morgan Stanley has acquired a majority stake in an Indian healthcare ......
Healthcare
Temasek eyes multiple targets for bolt-on acquisitions in healthcare
Singapore’s state investment firm Temasek, one of the two sovereign funds of the city state, is actively evaluating ......
Healthcare
General Atlantic-controlled Rubicon Research inks M&A ahead of IPO
Rubicon Research Ltd, a pharmaceutical products developer that is majority owned by private equity firm General Atlantic......
